(Q35584804)

9 August 2017

0 references

1 reference

title

Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis (English)

1 reference

9 August 2017

1 reference

1 reference

1 reference

8

Patrick M M Bossuyt

1 reference

9 August 2017

René Spijker

5

0 references

Jérémie F. Cohen

object named as

Jérémie F Cohen

4

0 references

Daniël Korevaar

1

object named as

Daniël A Korevaar

1 reference

9 August 2017

Guus A Westerhof

2

1 reference

9 August 2017

Junfeng Wang

3

1 reference

9 August 2017

Peter J Sterk

6

1 reference

9 August 2017

Elisabeth H Bel

7

1 reference

9 August 2017

publication date

20 March 2015

1 reference

The Lancet. Respiratory medicine

9 August 2017

published in

1 reference

9 August 2017

volume

3

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

290-300

1 reference

A large subgroup of mild-to-moderate asthma is persistently noneosinophilic

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Factors associated with persistent airflow limitation in severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Eosinophilic airway inflammation and the prognosis of childhood asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Systematic reviews of diagnostic test accuracy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Adult asthma biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Infrequent and incomplete registration of test accuracy studies: analysis of recent study reports

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Predicting steroid responsiveness in patients with asthma using exhaled breath profiling.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Nitric oxide in health and disease of the respiratory system

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Is a single blood eosinophil count a reliable marker for "eosinophilic asthma?"

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Clinically significant variability of serum IgE concentrations in patients with severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Advances in the clinical applications of exhaled nitric oxide measurements

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Consistency of sputum eosinophilia in difficult-to-treat asthma: a 5-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Transient sputum eosinophilia may occur over time in non-eosinophilic asthma and this is not prevented by salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Changing pattern of sputum cell counts during successive exacerbations of airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Can we predict sputum eosinophilia from clinical assessment in patients referred to an adult asthma clinic?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Clinical characteristics and possible phenotypes of an adult severe asthma population.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Moderate accuracy of peripheral eosinophil count for predicting eosinophilic phenotype in steroid-naïve non-atopic adult asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Full blood count parameters for the detection of asthma inflammatory phenotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Role of neutrophils in persistent airway obstruction due to refractory asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Non-invasive phenotyping using exhaled volatile organic compounds in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

The use of exhaled nitric oxide in the diagnosis of asthma in school children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Sputum induction in children with difficult asthma: safety, feasibility, and inflammatory cell pattern

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Longitudinal relationship between sputum eosinophils and exhaled nitric oxide in children with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

Airway inflammation and bronchial hyperreactivity in steroid naive children with intermittent and mild persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900050-8

7 January 2021

10.1016/S2213-2600(15)00050-8

Identifiers

DOI

1 reference

9 August 2017

1 reference